Quick Answer
MIRA PHARMACEUTICALS, INC. reported Total Assets of $11.09 million for fiscal year 2025.
MIRA PHARMACEUTICALS, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $11.09M | +279.5% |
| 2024 | $2.92M | -40.7% |
| 2023 | $4.93M | +474.8% |
| 2022 | $858.1K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $7.63M | +78.9% | +779.1% |
| June 30, 2025 | $868.3K | -71.2% | -38.0% |
| March 31, 2025 | $1.40M | -63.2% | -52.1% |
| December 31, 2024 | $2.92M | -40.7% | -31.5% |
| September 30, 2024 | $4.27M | -52.7% | +41.5% |
| June 30, 2024 | $3.02M | -21.2% | -20.8% |
| March 31, 2024 | $3.81M | — | -22.8% |
| December 31, 2023 | $4.93M | +474.8% | -45.3% |
- MIRA PHARMACEUTICALS, INC. showed an increase of +279.5% in Total Assets compared to the prior fiscal year.
- Over the 2022–2025 period, MIRA PHARMACEUTICALS, INC.’s total assets has grown by 1192.8% (from $858.1 thousand to $11.09 million).
- The most recent figure is from MIRA PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: